In conversation with....

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

July 19, 2022 The Lancet Diabetes & Endocrinology
In conversation with....
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
Show Notes

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma